Semler Scientific, Inc. (SMLR)

Longboard Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	42.98	56.29	68.18	56.69	53.03	38.6
Revenue Growth (YoY)	-30.39%	-17.44%	20.28%	6.90%	37.36%	17.81%
Cost of Revenue	3.94	4.76	4.51	4.25	6.12	3.36
Gross Profit	39.04	51.54	63.68	52.43	46.91	35.25
Selling, General & Admin	29.08	25.81	32.44	30.42	23.68	16.35
Research & Development	4.77	4.79	5.77	4.81	3.78	2.94
Operating Expenses	33.84	30.6	38.21	35.23	27.46	19.29
Operating Income	5.2	20.93	25.47	17.2	19.45	15.96
Interest Expense	-1.95	-	-	-	-	-
Interest & Investment Income	0.34	1.88	2.47	0.49	0.01	0.02
Other Non Operating Income (Expenses)	71.93	24.95	0.02	-0.01	-	0.06
EBT Excluding Unusual Items	75.53	47.76	27.95	17.69	19.46	16.04
Merger & Restructuring Charges	-	-	-0.73	-	-	-
Gain (Loss) on Sale of Investments	-1.14	0.13	-0.64	-	-	0.44
Asset Writedown	-	-	-2.48	-	-	-
Pretax Income	44.64	47.88	24.1	17.69	19.46	16.49
Income Tax Expense	7.6	6.99	3.52	3.37	2.23	2.48
Net Income	37.05	40.9	20.58	14.33	17.22	14.01
Net Income to Common	37.05	40.9	20.58	14.33	17.22	14.01
Net Income Growth	134.18%	98.70%	43.69%	-16.82%	22.95%	-7.14%
Shares Outstanding (Basic)	9	7	7	7	7	7
Shares Outstanding (Diluted)	9	8	8	8	8	8
Shares Change (YoY)	21.19%	2.06%	-2.26%	-1.71%	0.89%	0.46%
EPS (Basic)	4.07	5.66	3.06	2.13	2.56	2.13
EPS (Diluted)	3.94	5.13	2.63	1.79	2.12	1.74
EPS Growth	94.27%	95.06%	46.93%	-15.57%	21.84%	-7.45%
Free Cash Flow	12.18	24.36	20.5	15.3	15.23	14.36
Free Cash Flow Per Share	1.29	3.05	2.62	1.91	1.87	1.78
Gross Margin	90.84%	91.55%	93.39%	92.50%	88.45%	91.31%
Operating Margin	12.10%	37.19%	37.35%	30.35%	36.67%	41.35%
Profit Margin	86.19%	72.65%	30.19%	25.27%	32.48%	36.29%
Free Cash Flow Margin	28.34%	43.27%	30.07%	27.00%	28.72%	37.19%
EBITDA	5.41	21.22	25.76	17.41	19.63	16.1
EBITDA Margin	12.58%	37.69%	37.78%	30.71%	37.02%	41.70%
D&A For EBITDA	0.2	0.28	0.29	0.2	0.19	0.14
EBIT	5.2	20.93	25.47	17.2	19.45	15.96
EBIT Margin	12.10%	37.19%	37.35%	30.35%	36.67%	41.35%
Effective Tax Rate	17.02%	14.59%	14.59%	19.03%	11.48%	15.04%
Advertising Expenses	-	0.17	0.32	-	-	-

Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q